Medicus Pharma (NASDAQ:MDCX – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at D. Boral Capital in a note issued to investors on Tuesday,Benzinga reports. They ...

Bansal has driven a sharp rebound in Boral’s performance during his time, and will move onto the board of Stokes’ SGH group ...

Boral chief executive Vik Bansal will quit the building materials supplier in early 2026 after just three years in the top job, with investors in parent company SGH cautious about the succession ...

The businessman will leave the building materials giant he has run since 2022 and become a director of the Stokes family ...

Boral’s chief executive and managing director Vik Bansal intends to step down from his role at the construction materials and ...

Fintel reports that on June 30, 2025, D. Boral Capital downgraded their outlook for CorMedix (NasdaqGM:CRMD) from Buy to Hold ...

ASX edged higher as Wall Street hit fresh highs, gold climbed on rate-cut hopes, while SGH and HMC stumbled on leadership ...

Our Morningstar Capital Allocation Rating for SGH is Standard.

LONDON, Ontario, June 20, 2025("Aduro" or the "Company") (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company ...

Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company ...

D. Boral Capital LLC Email: [email protected] Telephone: +1 (212) 970-5150 SOURCE: D. Boral Capital This story was originally published June 12, 2025 at 3:30 PM.